Wednesday, September 23, 2026

TagsEMA

Tag: EMA

Healthcare

X4 Pharmaceuticals Announces EMA Validation of Marketing Authorization Application (MAA) for Mavorixafor – licenced to Norgine for commercialisation in Europe.

BFN's Desk - January 25, 2025 0

Insurance-Tips

Moving Averages Updates: HDFC Life Stock Price Breaks Above 20-Day EMA, Reaches Rs 586.75

BFN's Desk - February 28, 2024 0

Automobile

EMA Recommends Arpraziquantel for Treatment of Schistosomiasis in Preschool-Aged Children

BFN's Desk - December 18, 2023 0

Most Read

House of McDowell’s Soda Reimagines Yaari with ‘Yaari Ki Nayi Vibe’

September 20, 2026

Black Dog Scotch Whisky In New Packaging

September 11, 2026

Madhya Pradesh Unveils Roadmap to Cut Major Non-CO₂ Pollutants

September 8, 2026

Sanchi Gets a New Identity in Indore, Reinforcing Its 45-Year Legacy of Trust

August 26, 2026